Sec Form 13G Filing - TYBOURNE CAPITAL MANAGEMENT (HK) LTD filing for Forte Biosciences, Inc. (FBRX) - 2025-02-14

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
 
Signature:/s/ Catherine Cheung
Name/Title:Catherine Cheung, Chief Operating Officer
Date:02/14/2025
 
TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED
 
Signature:/s/ Viswanathan Krishnan
Name/Title:Viswanathan Krishnan, Director
Date:02/14/2025
 
Tybourne Capital Management Ltd
 
Signature:/s/ Viswanathan Krishnan
Name/Title:Viswanathan Krishnan, Principal
Date:02/14/2025
 
Tybourne Kesari Ltd
 
Signature:/s/ Viswanathan Krishnan
Name/Title:Viswanathan Krishnan, Principal
Date:02/14/2025
 
Krishnan Viswanathan
 
Signature:/s/ Viswanathan Krishnan
Name/Title:Viswanathan Krishnan, Individually
Date:02/14/2025
Exhibit Information

99.1 Joint Filing Agreement, executed by and among the Reporting Persons, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on February 14, 2024

primary_doc.xml